Abstract: Process for treating a flexible bi-constituent self-demolding silicone membrane used as a counterform particularly for resin transfer molding. The membrane is coated with a thin layer of at least one monoconstituent silicone which is a polysiloxane cross-linkable at ambient temperature in the presence of the moisture in air. The polysiloxane corresponds to the formula (I): in which: the substituents R3, R4, and R5 are selected from alkyl or aryl radicals, R6 represents an alkyloxy group, an alkenyloxy group, an alcanoyloxy group, an amino group, a ketiminoxy group, an amido group, an aminoxy group.

Abstract: The present invention relates to novel compounds and their pharmaceutical or diagnostic use, or use as a pharmacological target. More particularly, the present invention describes the identification of partners of the FE65 protein and the use of these partners, or of any compound which is capable of modulating, at least partially, their interaction with FE65, for regulating the activity of FE65, and in particular the phenomenon of intracellular transport or of endocytosis of the APP.

Abstract: The invention concerns novel peptides capable of interacting with the human topoisomerase III&agr; and the nucleic acid sequences coding for said polypeptides. The invention also concerns a method for identifying compounds capable of interacting with said polypeptides and a method for identifying molecules capable of modulating the interaction of the topoisomerase III&agr; with said polypeptides.

Abstract: In order to manufacture a sandwich panel using the RTM technique, a stack comprising a core (10) with open cells, a film (12) of intumescent material covering each of the faces of the core (10), a dry barrier fabric (14) covering each of the films (12) and an overlay of dry fibers (16) covering each of the barrier fabrics is placed in a mold. During polymerization of the films (12), pressurization of the mold and the presence of the barrier fabrics (14) prevent penetration of the foam into the overlays (16). The resin is then injected into the mold and then polymerized, without danger of penetration into the cells of the core (10).

Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Abstract: The invention concerns novel polypeptides capable of interacting with the human topoisomerase III&agr; and the nucleic acid sequences coding for said polypeptides. The invention also concerns a method for identifying compounds capable of interacting with said polypeptides and a method for identifying molecules capable of modulating the interaction of the topoisomerase III&agr; with said polypeptides.

Abstract: The present invention relates to novel compounds and their pharmaceutical or diagnostic use, or use as a pharmacological target. More particularly, the present invention describes the identification of partners of the FE65 protein and the use of these partners, or of any compound which is capable of modulating, at least partially, their interaction with FE65, for regulating the activity of FE65, and in particular the phenomenon of intracellular transport or of endocytosis of the APP.

Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Abstract: In order to manufacture a sandwich panel using the RTM technique, a stack comprising a core (10) with open cells, a film (12) of intumescent material covering each of the faces of the core (10), a dry barrier fabric (14) covering each of the films (12) and an overlay of dry fibers (16) covering each of the barrier fabrics is placed in a mold. During polymerization of the films (12), pressurization of the mold and the presence of the barrier fabrics (14) prevent penetration of the foam into the overlays (16). The resin is then injected into the mold and then polymerized, without danger of penetration into the cells of the core (10).

Abstract: Provided herein are novel polypeptides that are derived from human JNK3 proteins, variants of such polypeptides, their corresponding nucleotide sequences, and their uses.

Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Abstract: The invention discloses an aeroengine nacelle afterbody of the type comprising a common nozzle for exhausting the mixed hot and cold gases originating respectively from the fan duct and from the aeroengine combustion chamber, the said nozzle having a longitudinal axis more or less coincident with the axis of the said engine. The common exhaust nozzle consists of two half-nozzles which are more or less symmetric with respect to a plane containing the said longitudinal axis, the said half-nozzles being, on the one hand, individually hinged via one of their longitudinal edges to a support structure hanging down from the wing structure or from the fuselage of the aircraft and, on the other hand, lockable together along their opposite longitudinal edges.

Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Abstract: Process for treating a flexible bi-constituent self-demolding silicone membrane used as a counterform particularly for resin transfer molding. The membrane is coated with a thin layer of at least one monoconstituent silicone which is a polysiloxane cross-linkable at ambient temperature in the presence of the moisture in air.

Abstract: Provided herein are novel polypeptides that are derived from human JNK3 proteins, variants of such polypeptides, their corresponding nucleotide sequences, and their uses.

Abstract: The present invention relates to novel compounds and their uses, in particular their pharmaceutical or diagnostic uses or their use as pharmacological targets. More particularly, the present invention relates to a novel protein, referred to as PAP1, as well as to novel peptides and compounds which are capable of modulating, at least partially, the activity of parkin.